Cancer Research SABCS  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 5310-5315, September 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirosa, M.
Right arrow Articles by Ito, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirosa, M.
Right arrow Articles by Ito, N.

Modification of N-Methyl-N'-nitro-N-nitrosoguanidine-induced Forestomach and Glandular Stomach Carcinogenesis by Phenolic Antioxidants in Rats1

Masao Hirosa2, Shoji Fukushima, Yasushi Kurata, Hiroyuki Tsuda, Masae Tatematsu and Nobuyuki Ito

First Department of Pathology, Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan

The modifying effects of five phenolic antioxidants on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-initiated forestomach and glandular stomach carcinogenesis were investigated in male F344 rats. Groups of 20 rats were given an intragastric dose of 150 mg/kg body weight MNNG, and starting from 1 week later received diet supplemented with 0.8% catechol (CC), 1.0% 2-tert-butyl-4-methylphenol, 1.5% p-tert-butylphenol, 1.5% methylhydroquinone, 1.5% 4-methoxyphenol (4MP), or basal diet alone for 51 weeks. Further groups of 10–15 rats were maintained as controls without prior treatment with MNNG. The incidences of squamous cell carcinoma of the forestomach in MNNG-treated animals were significantly elevated by the diets containing CC (P < 0.001), 2-tert-butyl-4-methylphenol (P < 0.001), or p-tert-butylphenol (P < 0.01), while the development of carcinoma in situ was inhibited by 4MP (P < 0.01). Treatment with CC, 2-tert-butyl-4-methylphenol, p-tert-butylphenol, or 4MP alone induced forestomach hyperplasia at incidences of 86.7, 40, 93.3, and 100%, respectively. In the pyloric region of the glandular stomach, the development of adenomatous hyperplasia and adenocarcinoma after MNNG treatment was significantly enhanced by diet containing CC (P < 0.001). Moreover, treatment with CC alone induced 100% adenomatous hyperplasia and induced adenocarcinoma in 20% of animals. These results clearly demonstrated that while antioxidants causing proliferation in forestomach epithelium can markedly enhance carcinogenesis in this tissue, others displaying the same or greater potential for generating a hyperplastic response, like 4MP, can exert an inhibitory effect. In addition, it was shown that CC, which is widely present in our environment, is an unequivocal glandular stomach carcinogen also possessing strong enhancing activity for MNNG-induced lesion development.

1 This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture and a grant from the Ministry of Health and Welfare of Japan.

2 To whom requests for reprints should be addressed, at First Department of Pathology, Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan.

Received 1/11/88. Revised 5/25/88. Accepted 6/17/88.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. Morita, H. Arimochi, and Y. Ohnishi
In Vitro Cytotoxicity of 4-Methylcatechol in Murine Tumor Cells: Induction of Apoptotic Cell Death by Extracellular Pro-Oxidant Action
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 317 - 323.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
A. Hagiwara, Y. Takesada, H. Tanaka, S. Tamano, M. Hirose, N. Ito, and T. Shirai
Dose-dependent Induction of Glandular Stomach Preneoplastic and Neoplastic Lesions in Male F344 Rats Treated with Catechol Chronically
Toxicol Pathol, February 1, 2001; 29(2): 180 - 186.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
M. Hirose, K. Hakoi, S. Takahashi, T. Hoshiya, K. Akagi, Cuilin, K. Saito, H. Kaneko, and T. Shirai
Sequential Morphological and Biological Changes in the Glandular Stomach Induced by Oral Administration of Catechol to Male F344 Rats
Toxicol Pathol, July 1, 1999; 27(4): 448 - 455.
[Abstract] [PDF]


Home page
International Journal of ToxicologyHome page
F. A. Andersen
Amended Final Report On the Safety Assessment of Pyrocatechol
International Journal of Toxicology, January 1, 1997; 16(1_suppl): 11 - 58.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.